[Effectiveness and safety of lansoprazole in the treatment of Zollinger-Ellison syndrome. First six months of treatment]. (Record no. 9817296)

MARC details
000 -LEADER
fixed length control field 01474 a2200433 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250513155948.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 199901s 0 0 fre d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0399-8320
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Pospaï, D
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19990107
245 00 - TITLE STATEMENT
Title [Effectiveness and safety of lansoprazole in the treatment of Zollinger-Ellison syndrome. First six months of treatment].
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Gastroenterologie clinique et biologique
Date of publication, distribution, etc. Oct 1998
300 ## - PHYSICAL DESCRIPTION
Extent 801-8 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element 2-Pyridinylmethylsulfinylbenzimidazoles
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dose-Response Relationship, Drug
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Enzyme Inhibitors
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Gastric Acid
General subdivision metabolism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Gastric Mucosa
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lansoprazole
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Omeprazole
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Proton Pump Inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Secretory Rate
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Zollinger-Ellison Syndrome
General subdivision drug therapy
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Cadiot, G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Forestier, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ruszniewski, P
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Coste, T
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Escourrou, J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mignon, M
773 0# - HOST ITEM ENTRY
Title Gastroenterologie clinique et biologique
Related parts vol. 22
-- no. 10
-- p. 801-8

No items available.